Acellular Pertussis Completed Phase 2 Trials for Rotavirus Vaccine (DB10276)

IndicationStatusPhase
DBCOND0031302 (Acellular Pertussis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01090453Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy InfantsPrevention